Skip to content

About 1,190,000 results
  1. AstraZeneca signs $2 billion agreement with Quell to develop cell therapies Reuters (Reuters) - AstraZeneca said on Friday it had signed an agreement with Quell Therapeutics potentially worth more than $2 billion to develop cell therapies that could cure autoimmune diseases.

    AstraZeneca signs $2 billion agreement …

    www.msn.com/en-us/money/companies/astrazene…
    Quell Therapeutics, a leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system has announced that it has entered into a collaboration, exclusive option and license agreement with AstraZeneca to develop, manufacture and commercialize autologous, engineered Treg cell therapies for two autoimmune disease indications.

    Quell Therapeutics Signs Agreement wit…

    medtechalert.com/news/quell-therapeutics-signs-a…
  2. People also ask
    Is AstraZeneca partnering with quell Therapeutics?
    AstraZeneca has entered into an exciting collaboration, exclusive option and license agreement with Quell Therapeutics to develop multiple engineered T-regulator (Treg) cell therapies that have the potential to be curative in Type 1 Diabetes (T1D) and Inflammatory Bowel Disease (IBD) indications.

    AstraZeneca announces agreement with Quell Therapeutics

    www.astrazeneca.com/media-centre/press-releases/2023/…
    Can quell co-develop Treg cell therapies with AstraZeneca?
    Additionally, Quell retains an option, which can be exercised either after approval of an investigational new drug application or at the end of the phase I/II study, to co-develop Treg cell therapies from the T1D program with AstraZeneca in the United States.

    AstraZeneca (AZN) & Quell to Co-Develop Autoimmune Cell Therapies

    finance.yahoo.com/news/astrazeneca-azn-quell-co-develo…
    Why is quell Therapeutics partnering with Treg?
    This collaboration builds on our pioneering work to develop exquisitely engineered, multi-modular Treg cell therapies for immune disorders and provides excellent validation for the technologies and capabilities we have established,” said Iain McGill, Chief Executive Officer of Quell Therapeutics.

    Quell Therapeutics Signs a Collaboration, Exclusive Option and License …

    quell-tx.com/quell-therapeutics-signs-a-collaboration-excl…
    Is AstraZeneca a good stock to buy now?
    AstraZeneca currently has a Zacks Rank #3 (Hold). Some better-ranked stocks in the overall medical sector are Novartis NVS, Akero Therapeutics AKRO and Adaptimmune Therapeutics ADAP, each carrying a Zacks Rank #2 (Buy) at present. You can see t he complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

    AstraZeneca (AZN) & Quell to Co-Develop Autoimmune Cell Therapies

    finance.yahoo.com/news/astrazeneca-azn-quell-co-develo…
    Feedback
  3. AstraZeneca
    https://www.astrazeneca.com/media-centre/press...

    AstraZeneca announces agreement with Quell Therapeutics

    Explore further

    AstraZeneca signs $2 billion agreement with Quell to develop …
    reuters.com
    Quell Therapeutics Significantly Expands Clinical …
    quell-tx.com
    Quell Therapeutics Granted CTA Approval to Begin First …
    prnewswire.com
    Regulatory T-cell therapy for autoimmune and …
    pubmed.ncbi.nlm.nih.gov
    UCL spin out Quell Therapeutics joins forces with …
    ucl.ac.uk
    Recommended to you based on what's popular • Feedback
  4. Reuters
    https://www.reuters.com/business/healthcare...

    AstraZeneca signs $2 billion agreement with Quell to …

    WebJun 9, 2023 · June 9 (Reuters) - AstraZeneca said on Friday it had signed an agreement with Quell Therapeutics potentially worth more than $2 billion to develop cell therapies that could cure autoimmune...

    Explore further

    AstraZeneca Reaches Agreement With Quell Therapeutics …
    wsj.com
    AstraZeneca agreement with Quell Therapeutics
    markets.ft.com
    Recommended to you based on what's popular • Feedback

  5. Images of AstraZeneca signs agreement with Quell

    bing.com/images
    See all images
  6. Yahoo Finance
    https://finance.yahoo.com/news/quell-therapeutics...

    Quell Therapeutics Signs a Collaboration, Exclusive Option and …

  7. GlobeNewswire
    https://www.globenewswire.com/news-release/2023/06/...

    Quell Therapeutics Signs a Collaboration, Exclusive …

  8. QuellTX
    https://quell-tx.com/quell-therapeutics-signs-a...

    Quell Therapeutics Signs a Collaboration, Exclusive Option and …

  9. The Wall Street Journal
    https://www.wsj.com/articles/astrazeneca-reaches...

    AstraZeneca Reaches Agreement With Quell Therapeutics for Treg …

  10. Yahoo Finance
    https://finance.yahoo.com/news/astrazeneca-azn...

    AstraZeneca (AZN) & Quell to Co-Develop Autoimmune Cell …

  11. FT.com
    https://markets.ft.com/data/announce/full?dockey=...

    AstraZeneca agreement with Quell Therapeutics

  12. Bloomberg
    https://www.bloomberg.com/press-releases/2023-06...

    Quell Therapeutics Signs a Collaboration, Exclusive …

  13. FT.com
    https://markets.ft.com/data/announce/detail?dockey=...

    Quell signs collaboration with AstraZeneca - FT.com